Probiotics for treating eczema

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 11, 2018, Pages

  Makrgeorgou, Areti ^a   Leonardi Bee, Jo ^b   Bath Hextall, Fiona J ^b   Murrell, Dedee F ^c   Tang, Mimi L K ^d,e,f   Roberts, Amanda ^g   Boyle, Robert J ^h  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g Nottingham Support Group for Carers of Children with Eczema (NSGCCE)   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ATOPIC DERMATITIS; ECZEMA; GASTROINTESTINAL SYMPTOM; HEALTH CARE; HEALTH SCIENCE; HUMAN; LACTOBACILLUS; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SENSITIVITY ANALYSIS; SEQUENTIAL ANALYSIS; SEVERITY SCORING OF ATOPIC DERMATITIS; SKIN DISEASE ASSESSMENT; SLEEP DISORDER; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; ADULT; CHILD; FEMALE; INFANT; MALE; META ANALYSIS; MIDDLE AGED; PRESCHOOL CHILD; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ECZEMA; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85057501074     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006135.pub3     Document Type: Review

References (192)

1. Brouwer ML, Wolt-Plompen SA, Dubois AE, Van der Heide S, Jansen DF, Hoijer MA, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clinical and Experimental Allergy 2006;36(7):899-906. [CENTRAL: CN-00571157; PUBMED: 16839405]3073829
2. Cukrowska B, Ceregra A, Klewicka E, Slizewska K, Motyl I, Libudzisz Z. Probiotic lactobacillus casei and lactobacillus paracasei strains in treatment of food allergy in children [Probiotyczne szczepy lactobacillus casei i lactobacillus paracasei w leczeniu alergii pokarmowej u dzieci]. Przegla¸d Pediatryczny 2010;40(1):21-5. [CENTRAL: CN-00803280]3073831
3. Cukrowska B, Ceregra A, Rosiak I, Klewicka E, Slizewska K, Motyl I, et al. The influence of probiotic Lactobacillus casei and paracasei strains on clinical status of atopic eczema in children with food allergy on cow's milk proteins [Wplyw probiotycznych szczepów Lactobacillus casei i paracasei na przebieg kliniczny wyprysku atopowego u dzieci z alergia¸ pokarmowa¸ na bialka mleka krowiego]. Pediatria Wspolczesna 2008;10(2):67-70. [CENTRAL: CN-00707920]3073832
4. Drago L, Iemoli E, Rodighiero V, Nicola L, De Vecchi E, Piconi S. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. International Journal of Immunopathology and Pharmacology 2011;24(4):1037-48. [CENTRAL: CN-00843712; PUBMED: 22230409]3073835
5. Drago L, Toscano M, De Vecchi E, Piconi S, Iemoli E. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. Journal of Clinical Gastroenterology 2012;46(Suppl):S56-S63. [CENTRAL: CN-00967749; PUBMED: 22955359]3073834
6. Drago L, De Vecchi E, Toscano M, Vassena C, Altomare G, Pigatto P. Treatment of atopic dermatitis eczema with a high concentration of Lactobacillus salivarius LS01 associated with an innovative gelling complex: a pilot study on adults. Journal of Clinical Gastroenterology 2014;48(Suppl 1):S47-51. [CENTRAL: CN-01113253]3073837
7. Farid R, Ahanchian H, Jabbari F, Moghiman T. Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iranian Journal of Pediatrics 2011;21(2):225-30. [CENTRAL: CN-00894605]3073839
8. Flinterman AE, Knol EF, van Ieperen-van Dijk AG, Timmerman HM, Knulst AC, Bruijnzeel-Koomen CA, et al. Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. International Archives of Allergy and Immunology 2007;143(3):237-44. [PUBMED: 17290150]3073841
9. Folster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. British Journal of Dermatology 2006;155(6):1256-61. [CENTRAL: CN-00576925; PUBMED: 17107398]3073843
10. Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. American Journal of Clinical Dermatology 2010;11(5):351-61. [CENTRAL: CN-00762545; PUBMED: 20642296]3073845
11. Gobel R, Larsen, N, Molgaard C, Jakobsen M, Michaelsen KF. Probiotics to young children with atopic dermatitis: a randomized placebo-controlled trial. International Journal of Probiotics and Prebiotics 2010;5(2):53-60. [CENTRAL: CN-00803376]3073847
12. Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Abu Al-Soud W, Sørensen SJ, et al. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp lactis Bi-07. FEMS Microbiology Ecology 2011;75(3):482-96. [CENTRAL: CN-00771294; PUBMED: 21204871]3073848
13. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, et al. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clinical and Experimental Allergy 2011;42(1):112-22. [CENTRAL: CN-00843786; PUBMED: 22092692]3073850
14. Gromert N, Axelsson I. Lactobacillus reuteri effect on atopic eczema in childhood. Journal of Pediatric Gastroenterology and Nutrition 2009;43(Suppl 3):E148-9. [CENTRAL: CN-00980761]3073852
15. Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, et al. Randomised, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007;62(11):1270-6. [CENTRAL: CN-00619933; PUBMED: 17919141]3073854
16. Guo Y-H, Mou Y-D, Wang H-S, Guo Y-J. Clinical effect of microecologics as an adjuvant therapy on infants' eczema. Journal of Dalian Medical University 2015;37(6):571-88. [DOI: 10.11724/jdmu.2015.06.13]9424539
17. Han Y, Kim B, Ban J, Lee J, Kim BJ, Choi BS, et al. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatric Allergy and Immunology 2012;23(7):667-73. [CENTRAL: CN-00871398; PUBMED: 23050557]3073856
18. Hol J, van Leer EH, Elink Schuurman BE, de Ruiter LF, Samsom JN, Hop W, et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 2008;121(6):1448-54. [CENTRAL: CN-00639187; PUBMED: 18436293]3073858
19. Iemoli E, Trabattoni D, Parisotto S, Borgonovo L, Toscano M, Rizzardini G, et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. Journal of Clinical Gastroenterology 2012;46(Suppl):S33-40. [CENTRAL: CN-00871399; PUBMED: 22955355]3073860
20. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 2000;30(11):1604-10. [CENTRAL: CN-00330163; PUBMED: 11069570]3073862
21. Ivakhnenko O, Niankovskyy S. Clinical effectiveness of probiotics in complex treatment of infants with cow's milk allergy. Georgian Medical News 2013;216:39-45. [CENTRAL: CN-01123797; PUBMED: 23567307]3073864
22. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. Journal of Pediatric Gastroenterology and Nutrition 2003;36(2):223-7. [CENTRAL: CN-00435079; PUBMED: 12548058]3073866
23. Lin R-J, Qiu L-H, Guan R-Z, Hu S-J, Liu Y-Y, Wang G-J. Protective effect of probiotics in the treatment of infantile eczema. Experimental and Therapeutic Medicine 2015;9(5):1593-6. [CENTRAL: CN-01069064]3073868
24. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. Journal of Allergy and Clinical Immunology 1997;99(2):179-85. [CENTRAL: CN-00136911; PUBMED: 9042042]3073870
25. Matsumoto M, Ebata T, Hirooka J, Hosoya R, Inoue N, Itami S, et al. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Annals of Allergy, Asthma and Immunology 2014;113(2):209-16. [CENTRAL: CN-00998958; PUBMED: 24893766]3073872
26. Nermes M, Kantele JM, Atosuo TJ, Salminen S, Isolauri E. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clinical and Experimental Allergy 2010;41(3):370-7. [CENTRAL: CN-00779496; PUBMED: 21121981]3073874
27. Passeron T, Lacour J-P, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006;61(4):431-7. [CENTRAL: CN-00563037; PUBMED: 16512804]3073876
28. Roessler A, Forssten SD, Glei M, Ouwehand AC, Jahreis G. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study. Clinical Nutrition 2012;31(1):22-9. [CENTRAL: CN-00882332; PUBMED: 21963389]3073878
29. Roessler A, Friedrich U, Vogelsang H, Bauer A, Kaatz M, Hipler UC, et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clinical and Experimental Allergy 2008;38(1):93-102. [CENTRAL: CN-00621150; PUBMED: 18028460]3073879
30. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology 2003;111(2):389-95. [CENTRAL: CN-00413280; PUBMED: 12589361]9424540
31. Rosenfeldt V, Benfeldt E, Valerius NH, Paeregaard A, Michaelsen KF. Effects of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 2004;145(5):612-6. [CENTRAL: CN-00492535; CRSREF: 3073882; PUBMED: 15520759]9424541
32. Shafiei A, Moin M, Pourpak Z, Gharagozlou M, Aghamohammadi A, Aghamohamadi A, et al. Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial. Iranian Journal of Allergy, Asthma and Immunology 2011;10(1):21-8. [CENTRAL: CN-00801473; PUBMED: 21358011]3073884
33. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clinical and Experimental Allergy 2006;36(5):629-33. [CENTRAL: CN-00564896; PUBMED: 16650048]3073886
34. Hattori K, Yamamoto A, Sasai M, Taniuchi S, Kojima T, Kobayashi Y, et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi [Allergy] 2003;52(1):20-30. [CENTRAL: CN-00558320; PUBMED: 12598719]3073888
35. Taniuchi S, Hattori K, Yamamoto A, Sasai M, Hatano Y, Kojima T, et al. Administration of Bifidobacterium to infants with atopic dermatitis: changes in fecal microflora and clinical symptoms. Journal of Applied Research 2005;5(2):387-96. [CENTRAL: CN-00569597]3073889
36. Van Der Aa LB, Van Aalderen WM, Heymans HS, Henk Sillevis Smitt J, Nauta AJ, Knippels LM, et al. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011;66(2):170-7. [CENTRAL: CN-00779370; PUBMED: 20560907]3073891
37. Van der Aa LB, Heymans HS, van Aalderen WM, Sillevis Smitt JH, Knol J, Ben Amor K, et al. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clinical and Experimental Allergy 2010;40(5):795-804. [CENTRAL: CN-00761390; PUBMED: 20184604]3073892
38. Van der Aa LB, Lutter R, Heymans HS, Smids BS, Dekker T, van Aalderen WM, et al. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. Clinical and Experimental Allergy 2012;42(4):531-9. [CENTRAL: CN-00839910; PUBMED: 22092915]3073893
39. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. Journal of Allergy and Clinical Immunology 2004;114(1):131-6. [CENTRAL: CN-00480315; PUBMED: 15241356]3073895
40. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatric Allergy and Immunology 2005;16(1):65-71. [CENTRAL: CN-00520986; PUBMED: 15693914]3073896
41. Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, et al. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. Journal of Allergy & Clinical Immunology 2005;115(6):1254-9. [CENTRAL: CN-00515574; PUBMED: 15940143]3073897
42. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005;60(4):494-500. [CENTRAL: CN-00513132; PUBMED: 15727582]3073898
43. Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clinical & Experimental Allergy 2015;45(4):779-87. [CENTRAL: CN-01069031; PUBMED: 25600169]3073900
44. Prescott SL, Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clinical and Experimental Allergy 2005;35(12):1557-64. [PUBMED: 16393321]3073902
45. Weston S, Dunstan J, Roper J, Breckler L, Halbert A, Richmond P, et al. Probiotics provide clinical benefit in moderate and severe atopic dermatitis: a randomised controlled trial. Journal of Investigative Dermatology 2005;125:596. 3073903
46. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Archives of Disease in Childhood 2005;90(9):892-7. [CENTRAL: CN-00521688; PUBMED: 15863468]3073904
47. Weston S, Richmond P, Halbert A, Prescott SL. Effects of probiotics in infants with atopic dermatitis: a randomised double blind placebo controlled trial. Australasian Journal of Dermatology 2004;45:A13. [CENTRAL: CN-00594250]3073905
48. Woo SI, Kim JY, Lee YJ, Kim NS, Hahn YS. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Annals of Allergy, Asthma and Immunology 2010;104(4):343-8. [CENTRAL: CN-00742516; PUBMED: 20408346]3073907
49. Wu KG, Li TH, Peng HJ. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety. British Journal of Dermatology 2012;166(1):129-36. [CENTRAL: CN-00841293; PUBMED: 21895621]3073909
50. Wu Y-J, Wu W-F, Hung C-W, Ku M-S, Liao P-F, Sun H-L, et al. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: an 8-week, double-blind, randomized, placebo-controlled study. Journal of Microbiology, Immunology and Infection 2017;50(5):684-92. [DOI: 10.1016/j.jmii.2015.10.003; PUBMED: 26733351]9424543
51. Yang H-J, Min TK, Lee HW, Pyun BY. Efficacy of probiotic therapy on atopic dermatitis in children: a randomized, double-blind, placebo-controlled trial.. Allergy, Asthma & Immunology Research 2014;6(3):208-15. [CENTRAL: CN-00988082; EMBASE: 2014300281]3073911
52. Yesilova Y, Calka O, Akdeniz N, Berktas M. Effect of probiotics on the treatment of children with atopic dermatitis. Annals of Dermatology 2012;24(2):189-93. [CENTRAL: CN-00861289; PUBMED: 22577270]3073913
53. Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, et al. Clinical effects of probiotic Bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Medica 2010;53(2):37-45. [CENTRAL: CN-00865095]3073915
54. Arkwright PD, David TJ. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. British Journal of Dermatology 2003;149(5):1029-34. [CENTRAL: CN-00472817; PUBMED: 14632810]3073917
55. Arvola T, Ruuska T, Keranen J, Hyoty H, Salminen S, Isolauri E. Rectal bleeding in infancy: clinical, allergological, and microbiological examination. Pediatrics 2006;117(4):e760-8. [CENTRAL: CN-00556020; PUBMED: 16585287]3073919
56. Aryayev ML, Kukushkin NV. Combined therapy with pimecrolimus cream 1% and probiotic in children with atopic dermatitis. European Journal of Pediatrics 2006;165(Suppl 1):53. [CENTRAL: CN-00764255]3073921
57. Burks AW, Harthoorn LF, Langford JE, Van Ampting MT, Goldberg SB, Ong PY, et al. Functional effects of an amino-acid based formula with synbiotics in cow's milk allergic infants. Allergy 2013;68(Suppl 97):703. [CENTRAL: CN-00985742; EMBASE: 71369861]3073923
58. Chernyshov PV. Randomized, placebo-controlled trial on clinical and immunologic effects of probiotic and emollient in children with atopic eczema and cow milk allergy. Allergo Journal 2010;19(5):336-7. [EMBASE: 70284293]3073925
59. Chernysov PV. Randomized, placebo-controlled trial on clinical and immunologic effects of probiotic containing Lactobacillus rhamnosus R0011 and L. helveticus R0052 in infants with atopic dermatitis. Microbial Ecology in Health and Disease 2009;21(3-4):228-32. [EMBASE: 2010028537]3073926
60. Foekel C, Schubert R, Kaatz M, Schmidt I, Bauer A, Hipler UC, et al. Dietetic effects of oral intervention with mare's milk on the Severity Scoring of Atopic Dermatitis, on faecal microbiota and on immunological parameters in patients with atopic dermatitis. International Journal of Food Sciences and Nutrition 2009;60(Suppl 7):41-52. [CENTRAL: CN-00751360; PUBMED: 19462320]3073928
61. Gueniche A, Breton L. Vitreoscilla filiformis lysate, a probiotic profile for topical skin care. Journal of Investigative Dermatology 2009;129:S15. [EMBASE: 70384507]3073931
62. Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. British Journal of Dermatology 2008;159(6):1357-63. [CENTRAL: CN-00665626; PUBMED: 18795916]3073930
63. Gueniche AG, Breton L. Vitreoscilla filiformis lysate, a probiotic profile for topical skin care. European Journal of Immunology 2009;39:S658. [EMBASE: 70347441]3073932
64. Ikezawa Z, Kondo M, Okajima M, Nishimura Y, Kono M. Clinical usefulness of oral itraconazole, an antimycotic drug, for refractory atopic dermatitis. European Journal of Dermatology 2004;14(6):400-6. [CENTRAL: CN-00504055; PUBMED: 15564204]3073934
65. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo controlled trial. Lancet 2003;361(9372):1869-71. [CENTRAL: CN-00558789; PUBMED: 12788576]3073936
66. Laitinen K, Kalliomaki M, Poussa T, Lagstrom H, Isolauri E. Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. British Journal of Nutrition 2005;94(4):565-74. [CENTRAL: CN-00838395]3073938
67. Leung TF, Ma KC, Cheung LT, Lam CW, Wong E, Wan H, et al. A randomized, single-blind and crossover study of an amino acid-based milk formula in treating young children with atopic dermatitis. Pediatric Allergy and Immunology 2004;15(6):558-61. [CENTRAL: CN-00511281; PUBMED: 15610371]3073940
68. Matsumoto M, Aranami A, Ishige A, Watanabe K, Benno Y. LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clinical and Experimental Allergy 2007;37(3):358-70. [CENTRAL: CN-00641021; EMBASE: 2007128104]3073942
69. Moroi M, Uchi S, Nakamura K, Sato S, Shimizu N, Fujii M, et al. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. Journal of Dermatology 2011;38(2):131-9. [CENTRAL: CN-00778680; PUBMED: 21269308]3073944
70. Murosaki S, Yamamoto Y, Yotsumoto H, Kubo H, Nomoto S, Usuki K, et al. Effects of intake of syrup supplemented with nigerooligosaccharides and heat-killed Lactobacillus plantarum L-137 on skin symptom and immune function in patients with atopic dermatitis. Japanese Pharmacology and Therapeutics 2006;34(10):1087-96. [CENTRAL: CN-00707197]3073946
71. Ogawa T, Hashikawa S, Asai Y, Sakamoto H, Yasuda K, Makimura Y. A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS Immunology & Medical Microbiology 2006;46(3):400-9. [CENTRAL: CN-00563540; PUBMED: 16553814]3073948
72. Keet CA, Wood RA. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Pediatrics 2008;122(Suppl 4):S198-9. [EMBASE: 2009166612]3073950
73. Ou C-Y, Kuo H-C, Wang L, Hsu T-Y, Chuang H, Liu C-A, et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clinical and Experimental Allergy 2012;42(9):1386-96. [CENTRAL: CN-00850372; EMBASE: 2012510284; PUBMED: 22925325]3073951
74. Rose MA, Schubert R, Schulze J, Zielen S. Follow-up of probiotic Lactobacillus GG effects on allergic sensitization and asthma in infants at risk. Clinical and Experimental Allergy 2011;41(12):1819-21. [CENTRAL: CN-00834541]3073953
75. Rose MA, Stieglitz F, Köksal A, Schubert R, Schulze J, Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clinical and Experimental Allergy 2010;40(9):1398-405. [CENTRAL: CN-00767900; PUBMED: 20604800]3073954
76. Shibata R, Kimura M, Takahashi H, Mikami K, Aiba Y, Takeda H, et al. Clinical effects of kestose, a prebiotic oligosaccharide, on the treatment of atopic dermatitis in infants. Clinical and Experimental Allergy 2009;39(9):1397-403. [CENTRAL: CN-00719173; PUBMED: 19508323]3073956
77. Shibata R, Koga Y, Takeda H, Nishima S. Clinical effects of prebiotics with kestose, a fructo-oligosaccharide, on atopic dermatitis in infants. Allergy 2009;64:447. [CENTRAL: CN-01029517]3073957
78. Torii S, Torii A, Itoh K, Urisu A, Terada A, Fujisawa T, et al. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. International Archives of Allergy and Immunology 2011;154(3):236-45. [CENTRAL: CN-00779204; PUBMED: 20861645]3073959
79. ACTRN12605000615684 . Probiotics in the management of eczema [A double-blind, randomised, placebo controlled study to identify markers for the differential response of children with eczema following treatment with probiotics]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=782 (first received 23 September 2005). 9424545
80. Candy DCA, Van Ampting MTJ, Oude Nijhuis MM, Wopereis H, Butt AM, Peroni DG, et al. Dietary management of non-IgE mediated cow's milk allergic infants with a synbiotics-supplemented amino acid-based formula: effects on faecal microbiota and clinical symptoms. Journal of Pediatric Gastroenterology, Hepatology and Nutrition. Lippincott Williams and Wilkins, 2016:S402. 9424547
81. Hulshof L, Overbeek SA, Wyllie Al, Chu Mj, Bogaert D, Jager W, et al. Dietary intervention with a synbiotic mixture of scGOS/lcFOS with Bifidobacterium breve M-16V in infants with atopic dermatitis shows beneficial immunological changes in chemokine profiles. Allergy: European Journal of Allergy and Clinical Immunology 2017;72:309-10. [CENTRAL: CN-01417584]9424549
82. NCT02585986 . Intervention study to evaluate a probiotic in mild atopic dermatitis young patients [Randomized, double blind, placebo-controlled Intervention study to evaluate safety and efficiency of a probiotic in symptoms reduction and use of topic corticoids in mild atopic dermatitis patients aged 4 to 17 years]. clinicaltrials.gov/ct2/show/NCT02585986 (first received 13 October 2015). 9424551
83. Prakoeswa CRS, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Beneficial Microbes 2017;8(5):833-40. [CENTRAL: CN-01420752]9424553
84. ChiCTR1800015330 . Effects of probiotics on inflammation and intestinal microflora in patients with atopic dermatitis. www.chictr.org.cn/showprojen.aspx?proj=24603 (first received 23 March 2018). 9424555
85. CTRI/2017/08/009236 . A study to observe if probiotics supplementation is helpful in atopic dermatitis children. apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/08/009236 (first received 2 August 2018). 9424557
86. CTRI/2017/10/010018 . Probiotics in treatment of atopic dermatitis in children. apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/10/010018 (first received 6 October 2017). 9424559
87. KCT0000914 . A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of IRT5 probiotics on atopic dermatitis in children [IRT5 probiotics atopic dermatitis]. cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=3350 (accessed before 7 December 2016). 9424561
88. NCT02519556 . Trial on effectiveness combined probiotics in atopic dermatitis in children [Randomized, double blind, controlled trial on effectiveness combined probiotics in the treatment of atopic dermatitis in children up to 6 months]. clinicaltrials.gov/ct2/show/NCT02519556 (first received 4 August 2015). 9424563
89. NCT02945683 . Effects of Lactobacillus reuteri plus vitamin D3 in children with atopic dermatitis. clinicaltrials.gov/ct2/show/NCT02945683 (first received 26 October 2016). 9424565
90. Abrahamsson TR, Jakobsson HE, Andersson AF, Björksten B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. Journal of Allergy and Clinical Immunology 2012;129(2):434-40. [PUBMED: 22153774]
91. Abuabara K, Yu AM, Okhovat JP, Allen E, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 2018;73(3):696-704. [DOI: 10.1111/all.13320; PUBMED: 28960336]
92. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003048.pub2]
93. Allingstrup M, Wetterslev J, Ravn FB, Moeller AM, Afshari A. Antithrombin III for critically ill patients. Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD005370.pub3]
94. Atkins D, Best D, Priss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328(7454):1490-4. [PUBMED: 15205295]
95. Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. British Journal of Dermatology 2007;156(4):791. [PUBMED: 17300244]
96. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. British Journal of Dermatology 2006;155(1):145-51. [DOI: 10.1111/j.1365-2133.2006.07185.x; PUBMED: 16792766]
97. Beck LA, Leung DY. Allergen sensitization through the skin induces systemic allergic responses. Journal of Allergy & Clinical Immunology 2000;106(5 Suppl):S258-63. [PUBMED: 11080741]
98. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised double-blind placebo-controlled trial. Lancet 2008;371(9613):651-9. [PUBMED: 18279948 ]
99. Bieber T. Atopic dermatitis. New England Journal of Medicine 2008;358(14):1483-94. [PUBMED: 18385500]
100. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology 2001;108(4):516-20. [PUBMED: 11590374]
101. Bohme M, Svensson A, Kull I, Nordvall SL, Wahlgren CF. Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study. Acta Dermato-Venereologica 2001;81(3):193-7. [PUBMED: 11558876]
102. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clinical Infectious Diseases 2003;36(6):775-80. [PUBMED: 12627362]
103. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks?. American Journal of Clinical Nutrition 2006;83(6):1256-64. [PUBMED: 16762934]
104. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. [PUBMED: 18411040]
105. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98. [PUBMED: 18824466]
106. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Applied & Environmental Microbiology 2006;72(4):3050-3. [PUBMED: 16598017]
107. Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ. Gastrointestinal symptoms in atopic eczema. Archives of Disease in Childhood 1998;78(3):230-4. [PUBMED: 9613352]
108. Chang YS, Trivedi MK, Jha A, Lin Y-F, Dimaano L, Garcia-Romero MT. Synbiotics for prevention and treatment of atopic dermatitis. JAMA Pediatrics 2016;170(3):236-42. [DOI: 10.1001/jamapediatrics.2015.3943; PUBMED: 26810481]
109. Charman C, Williams HC. Epidemiology. In: Thomas Bieber, Donald YM Leung editor(s). Atopic Dermatitis. 1st Edition. New York: Marcel Dekker Inc, 2002:21-42.
110. Cherifi S, Robberecht J, Miendje Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clinica Belgica 2004;59(4):223-4. [PUBMED: 15597730]
111. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of SKINDEX, a quality-of-life instrument for patients with skin diseases. Archives of Dermatology 1997;133(11):1433-40. [PUBMED: 9371029]
112. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. Journal of Immunology 2002;168(1):171-8. [PUBMED: 11751960]
113. Connolly E, Abrahamsson T, Bjorksten B. Safety of D(-)-lactic acid producing bacteria in the human infant. Journal of Pediatric Gastroenterology & Nutrition 2005;41(4):489-92. [PUBMED: 16205524]
114. Dang D, Zhou W, Lun ZJ, Mu X, Wang DX, Wu H. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. Journal of International Medical Research 2013;41(5):1426-36. [PUBMED: 23908398]
115. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatric Infectious Disease Journal 2005;24(3):278-80. [PUBMED: 15750472]
116. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opinion on Drug Safety 2014;13(2):227-39. [PUBMED: 24405164]
117. Diepgen TL, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores of atopic dermatitis incorporating criteria of data quality and practical usefulness. Journal of Clinical Epidemiology 1996;49:1031-8.
118. Doege K, Grajecki D, Zyrax BC, Dentinika E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood - a meta-analysis. British Journal of Nutrition 2012;107(1):1-6. [PUBMED: 21787448]
119. Duffy SW, Rohan TE, Altman DG. A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy. American Journal of Epidemiology 1989;130(2):371-8. [PUBMED: 2750732]
120. Dugoua JJ, Machado MM, Zhu X, Chen X, Koren G, Einarson T. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium and Saccharomyces spp. Journal of Obstetrics and Gynaecology Canada 2009;31(6):542-52. [PUBMED: 19646321]
121. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004;59(Suppl 78):86-92. [PUBMED: 15245365]
122. Eichenfield LF, Stein Gold LF. Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Seminars in Cutaneous Medicine and Surgery 2017;36(2 Suppl 2):S45-8. [PUBMED: 28654711]
123. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vaillancourt JM. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [PUBMED: 11914310]
124. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, et al. Cost of atopic dermatitis and eczema in the United States. Journal of the American Academy of Dermatology 2002;46(3):361-70. [PUBMED: 11862170]
125. Enomoto H, Hirata K, Otsuka K, Kawai T, Takahashi T, Hirota T, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study. Journal of Human Genetics 2008;53(7):615-21. [PUBMED: 18521703]
126. Ernst E, Pittler MH, Stevinson C. Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments. American Journal of Clinical Dermatology 2000;3(5):341-8. [PUBMED: 12069640]
127. Joint FAO/WHO Working Group. Guidelines for the evaluation of probiotics in food 2002. www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf?ua=1. London, Ontario, Canada, (accessed before 8 December 2016).
128. Fennessy M, Coupland S, Popay J, Naysmith K. The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research. Journal of Epidemiology & Community Health 2000;54(8):581-9. [PUBMED: 10890869]
129. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. British Journal of Dermatology 1996;135(4):509-15. [PUBMED: 8915137]
130. Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a World Allergy Organization position paper. World Allergy Organisation Journal 2012;5(11):148-67. [PUBMED: 23282383]
131. Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis?. Journal of Allergy and Clinical Immunology 2004;114(1):150-8. [PUBMED: 15241359]
132. Guarino A, Guandalini S, Lo Vecchio A. Probiotics for the prevention and treatment for diarrhea. Journal of Clinical Gastroenterology 2015;49(Suppl 1):S37-45. [PUBMED: 26447963]
133. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, et al. Safety of probiotics to reduce risk and prevent or treat disease. Evidence Report/ Technology Assessment Number 200. AHRQ Publication No. 11-E007. April 2011. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/probiotic-evidence-report.pdf (accessed before 8 December 2016).
134. Hennequin C, Kauffmann-Lacroix C, Jobert A, Viard JP, Ricour C, Jacquemin JL, et al. Possible role of catheters in Saccharomyces boulardii fungemia. European Journal of Clinical Microbiology and Infectious Diseases 2000;19(1):16-20. [PUBMED: 10706174]
135. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration. Available from www.cochrane-handbook.org.
136. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technology Assessment 2000;4(37):1-191. [PUBMED: 11134919]
137. Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. American Journal of Clinical Nutrition 2001;73(2 Suppl):365S-73S. [PUBMED: 11157343]
138. Huang R, Ning H, Shen M, Li J, Zhang J, Chen X. Probiotics for the treatment of atopic dermatitis in children: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Cellular and Infection Microbiology 2017;7:392. [DOI: 10.3389/fcimb.2017.00392; PUBMED: 28932705]
139. Ishibashi N, Yamazaki S. Probiotics and safety. American Journal of Clinical Nutrition 2001;73(2 Suppl):S465-70. [PUBMED: 11157359]
140. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi PV, Robins-Browne RM, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high risk infants. Paediatric Allergy and Immunology 2012;23(7):674-81. [PUBMED: 22831283]
141. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56(9):813-24. [PUBMED: 11551246]
142. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology 2004;113(5):832-6. [PUBMED: 15131563]
143. Juni P, Altman DG, Egger M. Assesing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6. [PUBMED: 11440947]
144. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. Journal of Allergy and Clinical Immunology 2001;107(1):129-34. [PUBMED: 11150002]
145. Kemp AS. Atopic eczema: its social and financial costs. Journal of Paediatrics and Child Health 1999;35(3):229-31. [PUBMED: 10404440]
146. Kim SO, Ah YM, Yu YM, Choi KH, Shin WG, Lee JY. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Annals of Allergy, Asthma, & Immunology 2014;113(2):217-26. [PUBMED: 24954372]
147. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology 2007;119(1):192-8. [PUBMED: 17208601]
148. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195(1):10-9. [PUBMED: 9267730]
149. Lamb SR, Rademaker M. Pharmacoeconomics of drug therapy for atopic dermatitis. Expert Opinion on Pharmacotherapy 2002;3(3):249-55. [PUBMED: 11866675]
150. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115(1):178-81. [PUBMED: 15629999]
151. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. British Journal of Dermatology 1998;138(1):107-13. [PUBMED: 9536231]
152. Lestin F, Pertschy A, Rimek D. Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities [Fungamie nach oraler Gabe]. Deutsche Medizinische Wochenschrift 2003;128(48):2531-3. [PUBMED: 14648435]
153. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. International Journal of Clinical Practice 2006;60(8):984-92. [DOI: 10.1111/j.1742-1241.2006.01047.x]
154. Makelainen H, Tahvonen R, Salminen S, Ouwehand AC. In vivo safety assessment of two Bifidobacterium longum strains. Microbiology & Immunology 2003;47(12):911-4. [PUBMED: 14695440]
155. Malik K, Heitmiller KD, Czarnowski T. An update on the pathophysiology of atopic dermatitis. Dermatologic Clinics 2017;35(3):317-26. [PUBMED: 28577801]
156. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatric Dermatology 2008;25(1):1-6. [PUBMED: 18304144]
157. Mansfield JA, Bergin SW, Cooper JR, Olsen CH. Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. Military Medicine 2014;179(6):580-92. [PUBMED: 24902123]
158. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Archives of Disease in Childhood 2006;91(10):814-9. [PUBMED: 16873437]
159. Murray CS, Tannock GW, Simon MA, Harmsen HJ, Welling GW, Custovic A, et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clinical and Experimental Allergy 2005;35(6):741-5. [PUBMED: 15969664]
160. Nankervis H, Thomas KS, Delamere FM, Barbarot S, Rogers NK, Williams HC. Scoping Systematic Review of Treatments for Eczema. 7th Edition. Vol. 4, Programme Grants for Applied Research, NIHR Journals Library, 2016. [PUBMED: 27280278]
161. Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H. FLG mutation p.Lys4021X in the C-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. British Journal of Dermatology 2009;161(6):1387-90. [PUBMED: 19663875]
162. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher IM, ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy and Clinical Immunology 2009;124(6):1251-8. [PUBMED: 20004783]
163. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006475.pub2]
164. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 2006;38(4):441-6. [PUBMED: 16550169]
165. Pineiro M, Stanton C. Probiotic bacteria: legislative framework - requirements to evidence basis. Journal of Nutrition 2007;137(3 Suppl 2):850S-3S. [PUBMED: 17311986]
166. Riquelme AJ, Calvo MA, Guzman AM, Depix MS, Garcia P, Perez C, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 2003;36(1):41-3. [PUBMED: 12488707]
167. Arden-Jones MR, Flohr C, Reynolds NJ, Holden CA. Atopic eczema. In: Griffiths CE, Barker J, Bleiker T, Chalmers R, Creamer D editor(s). Rook's Textbook of Dermatology. 9th Edition. Vol. 2, New York, NY: John Wiley & Sons, 2016.
168. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 2004;145(5):612-6. [PUBMED: 15520759]3073882
169. von Ruden U, Staab D, Kehrt R, Wahn U. Development and validation of a disease-specific questionnaire to measure quality of life in parents of children with atopic dermatitis [Entwicklung und Validierung eines krankheitsspezifischen Fragebogens zur Erfassung der Lebensqualitat von Eltern neurodermitiskranker Kinder]. Zeitschrift fur Gesundheitswissenschaften 1999;7:335-50. [DOI: 10.1007/BF02966499]
170. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, et al. Demonstration of safety of probiotics - a review. International Journal of Food Microbiology 1998;44(1-2):93-106. [PUBMED: 9849787]
171. Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. Journal of Allergy and Clinical Immunology 2013;132(6):1337-47. [PUBMED: 24035157]
172. Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012;67(1):99-106. [PUBMED: 21951293]
173. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. Journal of Allergy and Clinical Immunology 2013;132(5):1132-8. [PUBMED: 24094544]
174. Silverberg J. Selected co-morbidities of atopic dermatitis: atopy, neuropsychiatric and musculoskeletal disorders. Clinics in Dermatology 2017;35(4):360-6. [PUBMED: 28709566]
175. Simonyte Sjödin K, Vidman L, Rydén P, West CE. Emerging evidence of the role of gut microbiota in the development of allergic diseases. Current Opinion in Allergy and Clinical Immunology 2016;16(4):390-5. [PUBMED: 27253486]
176. Smethurst D. Atopic eczema. Clinical Evidence. 8th Edition. London: BMJ, 2002:1664-82.
177. Song H, Yoo Y, Hwang J, Na YC, Kim HS. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. Journal of Allergy and Clinical Immunology 2016;137(3):852-60. [PUBMED: 26431583]
178. Srinivasan R, Meyer R, Padmanabhan R, Britto J. Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. Journal of Pediatric Gastroenterology & Nutrition 2006;42(2):171-3. [PUBMED: 16456410]
179. Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet. Trial Sequential Analysis (TSA). Version 0.9.5.10 Beta. Copenhagen, Denmark: Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, 2017.
180. Vitaliti G, Pavone P, Guglielmo F, Spataro G, Falsaperla R. The immunomodulatory effect of probiotics beyond atopy: an update. Journal of Asthma 2014;51(3):320-32. [PUBMED: 24256057]
181. Wang M, Karlsson C, Olsson C, Adlerberth I, Wold AE, Strachan DP, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. Journal of Allergy and Clinical Immunology 2008;121(1):129-34. [PUBMED: 18028995]
182. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. Journal of Allergy and Clinical Immunology 2003;111(3):587-91. [PUBMED: 12642841]
183. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75. [PUBMED: 18083463]
184. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. [PUBMED: 20042080]
185. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. Journal of Allergy and Clinical Immunology 1999;103(1 Pt 1):125-38. [PUBMED: 9893196]
186. Williams HC. Clinical practice. Atopic dermatitis. New England Journal of Medicine 2005;352(22):2314-24. [PUBMED: 15930422]
187. Williams H, Stewart A, von Mutius E, Cookson W, Anderson RH, International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide. Journal of Allergy and Clinical Immunology 2008;121(4):947-54. [PUBMED: 18155278]
188. Wolf BW, Wheeler KB, Ataya DG, Garleb KA. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food & Chemical Toxicology 1998;36(12):1085-94. [PUBMED: 9862651]
189. Zhang H, Guo Y, Wang W, Shi M, Chen X, Yao Z. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis. Allergy 2011;66(3):420-7. [PUBMED: 21039602]
190. Zhu DL, Yang WX, Yang HM. Meta analysis of lactic acid bacteria as probiotics for the primary prevention of infantile eczema. Zhonqquo Dang Dai Er Ke Za Zhi 2010;12(9):734-9. [PUBMED: 20849726]
191. Boyle RJ, Bath-Hextall F, Donath S, Murrell D, Tang MLK, Taylor J, et al. Probiotics for atopic eczema. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006135]
192. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang MLK. Probiotics for treating eczema. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006135.pub2]